CAS: 106719-44-2; Boc-D-Lys-Oh

该化合物是氨基酸碱的一种受保护形式,通常用于peptide合成和有机化学."乙基"(乙基-丁基氧碳基)组是氨基功能的保护组,允许有选择的反应,而不会干扰该矿.该化合物的特征是其基本性,因为氨基氨基化合物的存在可以参与各种化学反应,包括浸泡物合成中的混合反应.该混合物组的存在在某些条件下增强了氨基酸的稳定性,使其更容易处理和储存.乙基-丁基-丁基碳基碳基(tert-bult-Boc)组通常是白色的固体,在二氯甲烷和二甲基红胺等有机溶剂中可溶解,但水溶解性较小.其应用范围扩大到聚醚和其他生物活性化合物的合成,使其在制药和生物化学研究中具有价值.正确处理和储存条件对于保持其完整性和再活动至关重要.

结构式图片

相似化合物

13734-28-6 10009-20-8 105047-45-8

欧盟法规

C&L通报

上下游产品

CAS号55878-47-2 (R)-6-(((苄氧基)羰基... | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号34404-32-5 Α-N-苄氧羰基-D-赖氨酸 | CAS号7274-88-6 D-赖氨酸盐酸盐 | CAS号106691-72-9 (R)-(2-氧代氮杂环庚烷-... | CAS号115186-31-7 N-B°C-N'-Fm°C-D-赖氨酸 | CAS号122546-52-5 N2-[(1,1-二甲基乙氧基...

合成工艺路线路线简述

    N2-[叔丁氧羰基]-N6-[苄氧羰基]-D-赖氨酸置于palladium On Activated Charcoal 氢气体系中,用 甲醇,水 用作溶剂,化学反应 24.0H,反应生成N-(叔丁氧羰基)-D-赖氨酸
    参考文献:Acosta,C. Kirk; Bahr,Martin L.; Burdett,James E.,Journal Of Chemical Research,Miniprint,1991,# 5,P. 914-934
    标题:Acosta,C. Kirk; Bahr,Martin L.; Burdett,James E.,Journal Of Chemical Research,Miniprint,1991,# 5,P. 914-934

    海关参考信息

    专利信息


    专利号:US-6359144-B1
    优先权日:1997-02-04
    标 题 :Combinatorial libraries of bicyclic guanidine derivatives and compounds therein
    发明人:OSTRESH JOHN M; MEYER JEAN-PHILIPPE; DOOLEY COLETTE T; BLONDELLE SYLVIE E; SCHONER CHRISTA C; HOUGHTEN RICHARD A
    权利人:LION BIOSCIENCE AG
    摘要:The invention provides a rapid approach for combinatorial synthesis and screening of combinatorial libraries of bicyclic guanidine compounds. The present invention further provides the compounds made by the combinatorial synthesis and individually as well as methods of using the same.

    专利号:US-4301065-A
    优先权日:1977-05-25
    标 题 :Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
    发明人:BACH JEAN-FRANCOIS; DARDENNE MIREILLE; PLEAU JEAN-MARIE; HAMBURGER JEAN; BRICAS EVANGHELOS; MARTINEZ JEAN; BLANOT DIDIER; AUGER GENEVIEVE
    权利人:ANVAR
    摘要:The invention is concerned with novel polypeptides and processes for the synthesis thereof. It is concerned with compounds having the sequence X-Gln-Gly-Gly-Y in which Y represents -Ser-Asn and X represents Ser-, Lys-Ser-, Ala-Lys-Ser-, Glx-Ala-Lys-Ser-; Glx representing Pyro-Glu or Gln; and when X represents Glx-Ala-Lys-Ser-, Y may in addition represent -Ser; as well as their derivatives comprising one or two modified amino acids, with the exception of the unmodified compound PyroGlu-Ala-Lys-Ser-Gln-Gly-Ser-Asn. These polypeptides are useful as medicines.

    专利号:WO-9811438-A1
    优先权日:1996-09-13
    标题 :Synthesis of quinazolinone libraries and derivatives thereof
    上海予利生物科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yurlichem.com
    企业联系电话:021-37285141👤
    📞上海予利生物科技股份有限公司 ⚠️参考联系方式
    联系人:严经理
    电话:021-37285141
    手机:15000957566
    传真:021-37285142
    邮箱:yurlichem@hotmail.com
    通信地址: 上海市金山区秋实路688号F楼208室
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市金山区秋实路688号F楼208室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Diversity-Oriented Synthesis Of Macrocyclic Peptidomimetics
    作者:Albert Isidro-Llobet,Tiffanie Murillo,Paula Bello,Agostino Cilibrizzi,James T. Hodgkinson,Warren R. J. D. Galloway,Andreas Bender,Martin Welch,David R. Spring |发布日期:2011.4.26
    摘要:Structurally Diverse Libraries Of Novel Small Molecules Represent Important Sources Of Biologically Active Agents. In This Paper We Report The Development Of A Diversity-Oriented Synthesis Strategy For The Generation Of Diverse Small Molecules Based Around A Common Macrocyclic Peptidomimetic Framework, Containing Structural Motifs Present In Many Naturally Occurring Bioactive Compounds. Macrocyclic Peptidomimetics Are Largely Underrepresented In Current Small-Molecule Screening Collections Owing Primarily To Synthetic Intractability; Thus Novel Molecules Based Around These Structures Represent Targets Of Significant Interest, Both From A Biological And A Synthetic Perspective. In A Proof-Of-Concept Study, The Synthesis Of A Library Of 14 Such Compounds Was Achieved. Analysis Of Chemical Space Coverage Confirmed That The Compound Structures Indeed Occupy Underrepresented Areas Of Chemistry In Screening Collections. Crucial To The Success Of This Approach Was The Development Of Novel Methodologies For The Macrocyclic Ring Closure Of Chiral α-Azido Acids And For The Synthesis Of Diketopiperazines Using Solid-Supported N Methylmorpholine. Owing To Their Robust And Flexible Natures, It Is Envisaged That Both New Methodologies Will Prove To Be Valuable In A Wider Synthetic Context.

    合成参考文献


    参考文献:10.1038/s41563-025-02320-9
    摘要:Lin Y, Li M, Luo Z, Meng Y, Zong Y, Ren H, Yu X, Tan X, Liu F, Wei T, Cheng Q. Tissue-specific mRNA delivery and prime editing with peptide-ionizable lipid nanoparticles. Nat Mater. 2026 Jan;25(1):133–45. doi: 10.1038/s41563-025-02320-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知